Freephone Orderline0800 387732
Alpha Laboratories has partnered with a number of manufacturers in order to provide a range of high quality reagents and speciality products. Precision Biologic has developed a reputation globally for its innovative CryoCheck™ range of frozen plasmas for calibration, controls and reagents. Similarly BioData is also a recognised leader as the supplier of Platelet aggregation instrumentation and reagents.
Please select your area of interest from the box below.
The PAP-8E, Platelet Aggregation Profiler® is intended for use in clinical, research, university, biotechnology and pharmaceutical laboratories. The system measures the rate and extent of aggregation, agglutination, activation and inhibition reactions, as well as the determination of platelet function activity.
A comprehensive range of accessories for both the PAP-4 and PAP-8 ranges.
>>back to top
The PDQ centrifuge is intended to be used as a specialised clinical centrifuge to prepare standardised samples for platelet function testing.
A system of reagents and control plasmas for the evaluation of von Willebrand Syndrome. This assay is for the specific quantitation of ristocetin cofactoractivity in plasma.
Reconstituted ristocetin reagent stable for 7 days at 2-8C
Normal reference plasma standardised to World Health Organisation traceable reference material.
Available in 10-test and 20-test pack sizes for flexibility.
Each kit contains lyophillised platelets, reference plasma, abnormal control, ristocetin, tris-buffered saline and graph paper.
A standardised and fixed platelet suspension derived from human blood.Suitabe for use in quantitation of vWF plasma.
Used in the detection of von Willebrand Syndrome and identification of Bernard-Soulier Syndrome.
Intended for use in the establishment of a standard activity curve.
Intended to verify sensitivity and performance of vWF assay.
A range of reagents for the study of platelet activation and dysfunction.
Building on an intergrated line of high-quality frozen controls, calibrators and reagents - the latest offering fromCRYOcheck™ brand is Protein S. All products are simple and convenient, designed to give you peace ofmind and save time.
A clot-based assay for the quantitative determination of Protein S. The common pathway is initiated by Russell's viper venom reagent, converting factor X to Xa in the presence of activated protein C, bypassing all factors above the common pathway.
This unique product initiates the common pathway with Russell's viper venom, converting factor X to Xa, thus bypassing all factors prior to the common pathway.
Products listed below are designed to offer laboratories a range of testingmethods for Lupus Anticoagulant (LA) so that the recommendation to use,"Two or more tests.... to screen for LA before the diagnosis is excluded",can be met.
1. Brandt JT, Triplet DA, Alving B, Scherrer I, Criteria for the Diagnosis of Lupus.
A highly sensitive reagent that detects weak LA samples other test systems may miss.
CRYOcheck™ LA Sure
A high phospholipid concentration that neutralizes LA, therefore, demonstrates the correction needed to confirm the presence of LA.
>>Back to top
CRYOcheck™ Platelet Lysate
A source of phospholipids intended for use in the platelet neutralization procedure (PNP)
CRYOcheck™ Weak Lupus Positive Control
A weak positive LA control that challenges an assay's sensitivity to LA.
CRYOcheck™ Lupus Positive Control
Intended for use as a positive control for lupus anticoagulants (LA)
Manufacuted from fresh frozen 100% human plasma, no bovine additives.
Collected from:
Derived from congenitally deficient donors collected with sodium citrate.
Plasma for the calibration of quantitative haemostasis assays.
Plasma for controlling the accuracy of quantitative assays in the borderline and pathological range.
Plasma for controlling the accuracy of quantitative haemostasis assays in the normal range.
Normal control for the one-stage Prothrombin time (PT), Acitvated Parial Thromboplastin Time (APTT), and Fibrinogen
Abnormal control for the one-stage Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
Recommended for use as an abnormal control in quantitative fibrinogen assays.
A positive control for clot-based assays for activated Protein C resistance.
Contains 10 distinct plasmas: 5 vials contain plasma that have been screened negative for APCR, the remaining 5 have been genetically ested for factor VLeiden mutation. Four of these were from heterezygous donors and one was homozygous.
Manufactured from screened donors and supplied in sets of 25 representative individuals.